Fort Lauderdale, FL - (NewMediaWire) - March 7, 2019 - MediXall Group Inc., (OTCQB: MDXL), division of MediXall.com, a technology and innovation-driven organization focused on transforming the patient-provider experience, is pleased to announce today the company’s expansion into the eye care arena with the appointment of Dr. Howard J. Braverman to the MediXall Advisory Board.Dr. Braverman’ s distinguished career of more than 40 years in the eye care industry includes practicing optometry in Florida for more than 28 years, as well as serving as the President of the American Optometric Association. Most notably, he was the National Vision Director for Humana’s Employer Group Segment. Dr. Braverman will provide guidance and support on strategic initiatives, as well as homing in on the patient-provider experience, as he has years of industry experience working directly with patients.Patients today expect seamless and personalized experiences when it comes to their healthcare, which is why MediXall developed a new tool for physicians to engage their patients with the level of price transparency and digital convenience that they have come to expect in every other aspect of their lives. With Braverman’s direct patient-provider experience, he will guide MediXall on optimizing the new MediXall Patient Experience, so that it integrates patient relationship management/commerce with digital marketing solutions to help grow their practice, improve office efficiency, and optimize appointment capacity.“Dr. Braverman is well-known and respected throughout the healthcare industry and is an outstanding business person with strategic vision and excellent execution skills,” said Michael Swartz, President of MediXall. “We're fortunate to have Dr. Braverman on our advisory board to assist with the critical areas of identifying and pursuing key strategies to help facilitate MediXall’s roll-out into the Vision space. His impressive 40-year career in optometry, coupled with his experience serving in various leadership capacities within the healthcare industry, will be a valuable resource for our team as we continue to expand our services and streamline efficiency with our platform overall.”Dr. Braverman’s previous experience included serving as President of The Vision Division of CompBenefits, Inc. He was also the Chief Executive Officer of Ultimate Optical, a wholesale prescription optical laboratory that was part of CompBenefits’ family of companies.Dr. Braverman has also served in a leadership capacity as part of various board and professional organizations. Most notably, he was the President of the American Optometric Association from 2000 –2001. He was also President of the Southern Council of Optometrists in 1993 and named “Optometrist of the South” in 1998. In addition, he served as the Chairman of the Florida State Board of Optometry, has been a member of the Florida Optometric Association, and has served as a trustee of Nova Southeastern University. He is currently a member of the Board of Governors of the Health Professions of Nova Southeastern University.“As a leader in the eye care profession, I am looking forward to working with the MediXall Leadership team’s technology-driven innovations in the patient/ provider experience. MediXall’s digital innovations will be an invaluable aid to help optometrists improve their office efficiency, which in turn allows optometrists to improve the quality of care for patients that they serve every single day,” said Dr. Howard Braverman.As a member of the MediXall advisory board, Dr. Braverman will work closely with the MediXall leadership team to consult on business strategy and sales, marketing, and product plans, as well as identify additional market opportunities and new strategic partnerships for the company. Furthermore, he will provide strategic and tactical insights on finding new ways to help address patients’ vision wellness needs, drive more patients to providers, improve provider growth and profitability, and help develop an eye care marketing campaign.For more information, please ...

Anticipated Revenues Growing at a Staggering PaceNewport Beach, CA - (NewMediaWire) - March 07, 2019 - M Line Holdings, Inc. (OTC Pink: MLHC; "M Line" or the “Company”).After distributing our shareholder letter on February 26, 2019, we wanted to continue to provide more details about the progress of the individual subsidiaries. Our first update is about the Caravel Group. They are having a fantastic first quarter of 2019. Negotiations are in the final stages with many large US retail chains to put our VEA™ branded drinks (VEA™ Proactive Hydration and VEA™ caffeinated sparkling water) on their shelves within the retailers shelf reset schedules. Additionally, we continue to be incredibly excited by our newly formulated TORQUE® Sugar Free Energy Drink and consumer chosen new TORQUE® Flavor line extension. All three brands, TORQUE® Energy Drink, TORQUE® Sugar Free and soon to be announced TORQUE® Flavor Line Extension are receiving very positive feedback from distributors and retailers. On the international stage we are also having great success. Caravel is in negotiations with international distribution partners for the VEA™ Brands and the TORQUE® Energy brands. Our distributor in Mexico is increasing their current purchase orders due to the excitement for the Caravel brands from Mexico’s key retailers.Our first orders of Lorenzo Caputo wine will be available for distribution later this month and we expect rapid growth once the wine brand appears on the TLC Channel, hot non-scripted show, Long Island Medium.Tony Anish, CEO of M Line, commented: “The growth in business that we are experiencing is far beyond what we expected for this year. The sales team at Caravel are doing an amazing job with our beverages. Tony continued: “I want to take this opportunity to again thank all our shareholders for believing in us. We recognize that the most important issue for shareholders is increased shareholder value. As management, we knew that it would take significant funds to build our group of companies and now, in an effort to achieve improved shareholder value, we have taken the following very important steps:I will be negotiating with our debt holders to freeze all dilution for an extended period of time. More details will be given next week.We will be announcing full details of the public company acquisition next week and we will consolidate its results with MLHC. This is not a spin-off but part of our growth.We will announce details next week of our plans to issue a dividend of a portion of the public company stock we acquire, subject to regulatory approval.The current and future prospects of MLHC has never looked brighter and because of the hard work of management and the support of our shareholders, we are now in the position to freeze dilutive measures to help increase the price of our shares”About M Line Holdings, Inc.M Line is a Holding Company. It controls subsidiaries involved in the Beverage Branding and Distribution industry that includes our branded drinks. In addition, M Line controls two subsidiaries in Florida in the Food and Beverage distribution business and M Line has now expanded into the Cannabis Industry with the acquisition of our C-Pod manufacturing business. M Line owns three restaurants and an event center in Arizona and land for development. M Line will continue with its business financing activities while looking for other opportunities in the Beverage, Distribution, hospitality and Cannabis industries as well as other prospects that make sense to management.Safe Harbor and Informational StatementThis press release may contain forward-looking information within the meaning of Section 21E of the Security Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statement of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial conditions or results of operations; (iii): the company's ...

DENVER, CO - (NewMediaWire) - March 07, 2019 - Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life”, ”the Company”), an international adaptive healthcare solutions company, today announced that it has broken ground on its first Community Clinic and Dispensing Pharmacy for the treatment of diabetes in the Republic of Vanuatu. The Company held a groundbreaking event at 11:00 a.m. on March 5th in Erakor Village, Vanuatu where the Paramount Chief welcomed Phoenix Life officials, such as Global Head of Security and Transport, Former Police Commissioner John Taleo, Head of National Healthcare, Former Director of Port Vila Central Hospital, the Department of Curative & Hospital Services and Vanuatu’s Ministry of Health, Dr. Santus Wari, and Martin Tindall, Phoenix Life CEO and Founder.According to the International Diabetes Federation, 1 in 10 Vanuatu citizens are diagnosed with diabetes every year. This is why Denver-based Phoenix Life chose to tackle diabetes in The Republic of Vanuatu, with a focus on addressing the national diabetes epidemic with Phoenix Metabolic, a plant based pharmaceutical, extracted from the cannabis plant and designed to specifically manage diabetes and its complications. Phoenix Life intends to deliver programs to make diabetes healthcare more accessible and affordable for national healthcare system providers, such as governments in the developing and least developed nations. “We appreciate the work that Phoenix Life Sciences International is doing in the Republic of Vanuatu to create a solution for our diabetes epidemic using botanical medicine. We’re sorry we were unable to attend the groundbreaking at Erakor Village but we are very excited for the commencement of Phoenix Life’s national diabetes screening and management program in the upcoming months,” said Vanuatu Minister of Health Hon. Jack Norris Kalmet.At the event, Dr. Santus Wari gave a speech on the benefits of this clinic and stressed the importance of citizens participating in blood sugar testing to better understand their health. Phoenix Life CEO Martin Tindall explained the company’s plans to open a national network of Phoenix Life Community Clinics and Dispensing Pharmacies over the next year. Further, Tindall explained that Phoenix Life plans to conduct clinical trials in Vanuatu, to be overseen by leading endocrinologists from Australia and the United States. These double blind randomized clinical trials will be used to confirm the efficacy of Phoenix Metabolic as a treatment for diabetes as part of Phoenix Life’s global rollout strategy.Through this Community Clinic and future locations, Phoenix Life plans to increase healthcare infrastructure throughout the nation to promote better health and provide significant improvements in healthcare, initially in the field of diabetes management. Now at locations around the Island Nation and at the event, Phoenix Life offers complimentary blood sugar screenings to test for diabetes and pre-diabetes in the population. Approximately 400 people were screened at the event. Attendees were served a healthy lunch made of traditional Vanuatu cuisine (Island Kai Kai) and taught about ways to improve their health through clean eating habits. “Diabetes is a disease that affects millions across the globe and is near to my heart as my family, like so many others, has been affected by it,” said Martin Tindall, CEO of Phoenix Life Sciences International Limited. “The groundbreaking of our first Community Clinic and Dispensing Pharmacy for the treatment of diabetes is an exciting next step for Phoenix Life as we work diligently to carry out our mission of transforming international healthcare.”The clinic will be the first of a national network of Community Clinics and Dispensing Pharmacies for Phoenix Life and will feature examination rooms, analytical labs, a dispensing pharmacy and other services for the health of the local people. As Phoenix Life continues rolling out its screening program “Sik Suka ? Jekem Ia !”, and a national network of Community Clinics and Dispensing ...

Los Angeles, CA - (NewMediaWire) - March 07, 2019 - NUGL Inc. (OTC: NUGL) (the “Company”), a one-stop shop for all things cannabis through the intelligent connection of consumers and companies, is pleased to announce its promotional partnership with the National Cannabis Industry Association (NCIA). The National Cannabis Industry Association has been a leader in defending state and federal laws, representing business and industry growth, and one of the largest and most established organizations in the industry.“NCIA’s proven impact and support of the cannabis industry is unprecedented and a key factor in getting this community to where we are today. To say it is influential is a massive understatement,” stated Bob Waters, V.P. of Sales, NUGL Inc. “NUGL is all about helping businesses grow in the cannabis space. Working with and through the NCIA, who epitomizes the term ‘canna-business first,’ is a natural fit for NUGL and its affiliate media outlets. Together, we will be able to leverage our consumer and business traffic and reach to help promote the cannabis community as well as advance NCIA’s efforts to progress the cannabis industry and NUGL Inc. as a whole.”“We are proud of the work NUGL has done informing cannabis producers about issues and developments that are important to them, and excited to join them in raising the standard of cannabis media and education,” said Aaron Smith, executive director of the National Cannabis Industry Association. “With NUGL’s help, we will be able to get more producers involved with our policy reform efforts on behalf of the industry, while connecting them to even more businesses and consumers.”NUGL launched its social media platform Tuesday March 5, 2019. "We plan on a 30 day launch with both NUGL 1.0 and NUGL 2.0 running parallel with one another. The platform is too big and we have too much traffic so we want to play it safe,” stated Ryan Bartlette, CMO, NUGL. “We will be offering features daily and moving the business platform over to work seamlessly with the active user platform.”NUGL’s social media platform is the first of its kind, offering real time map locations for users and businesses. It provides the most robust networking platform in the social media space and looks to expand into the mainstream market. About NCIAThe National Cannabis Industry Association is representing nearly 2,000 member-businesses and tens-of-thousands of cannabis professionals. NCIA is leading the charge to protect legal cannabis businesses, defend our state laws, and advance federal policy reforms. Successful businesses are joining NCIA every day to become stronger, smarter, and more prosperous by working together to defend and expand the responsible cannabis industry. Visit: www.ncia.comAbout NUGLNUGL is the world’s first cannabis search app built for the people, by the people. Our goal is to build the most user-friendly app experience in the cannabis industry by listening to our users and giving them what they want. NUGL is the only cannabis search app that offers equal and unbiased search results. We don’t sell top-spot listings or fake reviews, so our data stays true. Use NUGL to search for genuine user-rated dispensaries, strains, doctors, lawyers, cannabis service providers, vape shops, hydro stores, brands and more. NUGL’s flexible web app has no geographic limitations and can rapidly connect cannabis companies, related vertical services and users. The NUGL iOS and Android app brings a powerful cannabis search tool within reach of anyone, anytime, anywhere with the ease of a smartphone.For more information and updates, visit one of the links below.Website: http://www.nugl.com/ Facebook: https://www.facebook.com/nuglapp/Instagram: https://www.instagram.com/nuglapp/Twitter: https://twitter.com/nuglapp/LinkedIn: https://www.linkedin.com/company/nuglapp/Newsletter: https://nugl.us16.list-manage.com/subscribe?u=219fe8bb6995a19827c9f36cb&id=dc46712578Forward-Looking StatementsCertain statements in this press release may be considered "forward-looking statements" within the meaning of the ...

(NewMediaWire) - March 07, 2019 - DALLAS - A California physician-scientist with expertise in cardiovascular genetics and multimodal imaging has been recognized with a $10,000 cash award from the American Heart Association, the world’s leading health and wellness organization focused on heart and brain health, and Amazon Web Services through their collaboration in data mining research powered by innovative cloud technology. Rima Arnaout, M.D., from the University of California, San Francisco, received the award for progress in her cloud-based technology research work in automating echocardiogram images to rapidly and accurately analyze the heart’s function. This could ultimately make it faster to diagnosis various cardiovascular conditions. Arnaout, an assistant professor in medicine (cardiology) and a member of the UCSF Institute for Computational Health Sciences, has a background in genetics, clinical research and programming, and is a practicing cardiologist board-certified in multi-modality cardiovascular imaging. She is the latest researcher to receive the award given as a cash incentive from the American Heart Association and Amazon Web Services through the Association’s Institute for Precision Cardiovascular Medicine – dedicated exclusively to advancing precision medicine in cardiovascular research. “These specialized grants are designed to accelerate cardiovascular research at the intersection of science and technology using big data to fast-track precision treatments for cardiovascular disease,” said Jennifer Hall, Ph.D., Chief of the Institute for Precision Cardiovascular Medicine. “The Institute is encouraging researchers like Dr. Arnaout to push scientific discovery and demonstrate the power of data science. We hope others will be inspired by Rima’s work.” Leveraging machine learning technology, American Heart Association/Amazon Web Services grant recipients are transforming a one-size-fits-all healthcare to improve health outcomes. Innovative cloud technology can potentially give physicians and cardiologists precision health tools to provide enhanced prevention and treatment solutions. All grant awardees use Amazon Web Services computational cloud credits to leverage the power of cloud computing, open data and new artificial intelligence and machine learning tools available through the American Heart Association Precision Medicine Platform™. The American Heart Association Precision Medicine Platform, powered by Amazon Web Services cloud technology, is becoming a central hub to the cardiovascular and stroke research community to access vast and diverse datasets to accelerate scientific discovery. ### The American Heart Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information. About the American Heart Association The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies, and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1. About the American Heart Association’s Institute for Precision Cardiovascular Medicine The American Heart Association's Institute for Precision Cardiovascular Medicine aims to advance the science and practice of personalized medicine to improve the cardiovascular health of individuals and ...